Fitbit, Inc. has received US Food and Drug Administration clearance and the European Union's CE mark for its electrocardiogram app to assess users’ heart rhythms for atrial fibrillation (AFib) with a launch planned for October.
“Early detection of AFib is critical, and I’m incredibly excited that we are making these innovations accessible to people around...